Holdings
YieldMax(R) U.S. Stocks Target Double Distribution ETF
As of Jul 31, 2026, YieldMax(R) U.S. Stocks Target Double Distribution ETF reported 99 positions worth US$6.54M. Largest: Abbott Laboratories, Amgen Inc. and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abbott Laboratories | 2,893 | US$306K | +1,510 | Jul 31, 2026 |
| Amgen Inc. | 745 | US$287K | +322 | Jul 31, 2026 |
| Merck & Company, Inc. | 2,200 | US$286K | +865 | Jul 31, 2026 |
| Coca-cola Company (the) | 3,202 | US$280K | +1,149 | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 668 | US$277K | +121 | Jul 31, 2026 |
| Home Depot, Inc. (the) | 805 | US$267K | +371 | Jul 31, 2026 |
| Chevron Corporation | 1,329 | US$262K | +477 | Jul 31, 2026 |
| Procter & Gamble Company (the) | 1,798 | US$260K | +796 | Jul 31, 2026 |
| Verizon Communications Inc. | 5,405 | US$253K | +2,355 | Jul 31, 2026 |
| Pepsico, Inc. | 1,769 | US$247K | +793 | Jul 31, 2026 |